Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Crisis Management (E): North American Sporting League Visits Mexico City
Foster, GeorgeCaso SGSB-SPM40E-ELiderazgo y Dirección de personasA major sports league has decided to run its season opening game in Mexico City. When the teams arrive in the country four days before the event, two of Team A’s star players are kidnapped. The (A) case provides relevant background information about the league, the team, the players, and the planned activities surrounding the season opening game. It also describes what is initially known about the crisis situation. In cases (B) through (F), a...Desde 5,74 €
-
Kathy Giusti and the Multiple Myeloma Research Foundation
Hamermesh, Richard G.; Margolis, Joshua D.; Preble, MatthewCaso HBS-814026-EServicios y operacionesWhat do you do when your rising professional career is cut short by an unexpected cancer diagnosis? Kathy Giusti shifted careers, built a new organization that transformed how cancer research is done, and now faces the challenge of sustaining the organization and its funding for its newest venture. Since she was first diagnosed with multiple myeloma (MM) in 1996, Giusti had led an effort to better understand and treat the disease. She had co-fou...Desde 8,20 €
-
General Electric, 1984 (Spanish Version)
Aguilar, Francis J.; Hamermesh, Richard G.; Brainard, Caroline E.Caso HBS-302S36Conocimiento y comunicaciónDescribe los primeros cuatro años de permanencia de Jack Welch como CEO de las ofertas de General Electric Co. con las formas Welch ha tratado de actividades de estrategia y planificación del cambio de GE y sus intentos de hacer la empresa más empresarial.Desde 8,20 €
-
Privateer Holdings: Navigating a Rocketing, But Comples, Cannabis Marketplace
Foster, George; Melvin, SheilaCaso SGSB-E-646-EIniciativa emprendedoraPrivateer Holdings was a Seattle-based private equity firm that was “shaping the future of the legal cannabis industry.” In late 2017, Privateer held an expanding portfolio of global brands intended to “lead, legitimize, and define the future of cannabis” and was preparing to announce the closure of a Series C round that had raised more than $100 million. It was an opportune moment for its founding triumvirate to contemplate the future direct...Desde 8,20 €
-
Bloodbuy
Hamermesh, Richard G.; Norris, MichaelCaso HBS-815114-EIniciativa emprendedoraIn 2015, Chris Godfrey, founder and CEO of Bloodbuy has to consider the best path to growth for his young company that is attempting to disrupt the blood donation industry.Desde 8,20 €
-
Amylin Pharmaceuticals B
Hamermesh, Richard G.; Knoop, Carin-IsabelCaso HBS-813091-EIniciativa emprendedoraSupplement for case 809011Desde 8,20 €
-
Novasys Medical
Hamermesh, Richard G.; Barley, LaurenCaso HBS-810027-EIniciativa emprendedoraNovasys has developed a new medical device and procedure for the treatment of female stress urinary incontinence that is cheaper and can be performed in doctors' offices. In spite of FDA approval, the American Medical Association has been unwilling to approve the product for reimbursement. The case deals with the company's struggle to obtain a reimbursement code.Desde 8,20 €
-
Impact Investing for Cancer
Hamermesh, Richard G.; Preble, MatthewCaso HBS-818068-EDirección estratégicaDesde 8,20 €
-
Gene Patents (A)
Hamermesh, Richard G.; Kiron, David; Andrews, PhillipCaso HBS-811089-EIniciativa emprendedoraIn March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues deal with the potential implications of Judge Sweet's decision for biotechnology entrepreneurs and investors.Desde 8,20 €
-
Medalogix
Hamermesh, Richard G.; Preble, MatthewCaso HBS-815116-EIniciativa emprendedoraThis case examines an exciting new approach to health care that will help care providers identify when hospice services are the appropriate type of care for patients. The company, Medalogix, already has a product on the market that uses a proprietery algorithm to consider dozens of factors and determine when a patient qualifies for a hospice care eligability review. The product has started to gain traction, and the case explores how Medalogix can...Desde 8,20 €